Christine Neipert

About

Christine Neipert has over 15 years of experience in intellectual property, healthcare reimbursement, and technology commercialization. She has worked on both the entrepreneurial side, helping lead multiple funding rounds for companies such as Walden Biosciences and STAT3 Therapeutics, and on the venture capital side, assisting with target investment diligence. Christine’s expertise encompasses IP strategy and due diligence, as well as the development of commercialization pathways for innovative healthcare technologies, ensuring successful market entry and sustainability for emerging companies. She earned her PhD in Chemistry from the University of South Florida and her JD from Franklin Pierce Law Center.

Source (opens in a new tab)